Global Artificial Cornea Market Growth 2025-2031
Description
The global Artificial Cornea market size is predicted to grow from US$ 411 million in 2025 to US$ 645 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
An artificial cornea, also known medically as a keratoprosthesis, is a synthetic or bioengineered device designed to replace a damaged or diseased cornea when a traditional donor cornea transplant (keratoplasty) is not possible or has failed.
The global burden of corneal blindness has made the artificial cornea — or keratoprosthesis — an increasingly vital solution in modern ophthalmology. While traditional corneal transplantation remains the gold standard for restoring vision in patients with corneal opacity or damage, several factors drive the rising demand for artificial corneas when donor tissue is unavailable or unsuitable. Below is an in-depth look at the primary forces propelling the artificial cornea market forward.
Corneal disease ranks among the leading causes of blindness worldwide. Conditions such as keratoconus, corneal scarring from infections (like trachoma or herpes simplex virus), chemical burns, trauma, and degenerative disorders all contribute to corneal opacity. According to the World Health Organization, millions suffer from corneal blindness globally, with limited access to effective treatment in many regions. The growing incidence of these conditions fuels the need for advanced treatment options beyond traditional grafts, making artificial corneas a critical alternative.
The global demographic shift toward an aging population intensifies demand for eye care services. Age-related corneal disorders, including Fuchs’ endothelial dystrophy and other degenerative changes, increase the need for corneal replacement procedures. Older patients often have comorbidities or ocular surface diseases that make donor grafts less viable and more prone to failure — circumstances where keratoprostheses provide a promising solution.
A major limiting factor for corneal transplants worldwide is the chronic shortage of suitable donor tissue. The Eye Bank Association of America estimates that the supply-demand gap remains significant even in developed countries, while in low- and middle-income countries, donor cornea availability is critically low. This persistent shortfall drives patients and surgeons to consider artificial corneas as an alternative, especially in cases of repeat graft failures.
Recent innovations in biomaterials, nanotechnology, and bioengineering have dramatically improved the safety, biocompatibility, and optical performance of artificial corneas. Advances include improved polymers that mimic natural corneal properties, integration techniques that promote tissue adherence, and designs that reduce the risk of extrusion or infection. Companies and research institutions are also exploring bioengineered and 3D-printed corneal substitutes, paving the way for scalable, cost-effective, and patient-specific implants.
LP Information, Inc. (LPI) ' newest research report, the “Artificial Cornea Industry Forecast” looks at past sales and reviews total world Artificial Cornea sales in 2024, providing a comprehensive analysis by region and market sector of projected Artificial Cornea sales for 2025 through 2031. With Artificial Cornea sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Cornea industry.
This Insight Report provides a comprehensive analysis of the global Artificial Cornea landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Cornea portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Cornea market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Cornea and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Cornea.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Cornea market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Boston Keratoprosthesis
OOKP
Other
Segmentation by Application:
Hospitals
Ophthalmology Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CorNeat Vision
EyeYon Medical
KeraMed
Aurolab
LinkoCare Life Sciences
MicroKPro
Biomedical Sciences
Yueqing Regenerative Medicin
Jiayue Meishi Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Cornea market?
What factors are driving Artificial Cornea market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Cornea market opportunities vary by end market size?
How does Artificial Cornea break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
An artificial cornea, also known medically as a keratoprosthesis, is a synthetic or bioengineered device designed to replace a damaged or diseased cornea when a traditional donor cornea transplant (keratoplasty) is not possible or has failed.
The global burden of corneal blindness has made the artificial cornea — or keratoprosthesis — an increasingly vital solution in modern ophthalmology. While traditional corneal transplantation remains the gold standard for restoring vision in patients with corneal opacity or damage, several factors drive the rising demand for artificial corneas when donor tissue is unavailable or unsuitable. Below is an in-depth look at the primary forces propelling the artificial cornea market forward.
Corneal disease ranks among the leading causes of blindness worldwide. Conditions such as keratoconus, corneal scarring from infections (like trachoma or herpes simplex virus), chemical burns, trauma, and degenerative disorders all contribute to corneal opacity. According to the World Health Organization, millions suffer from corneal blindness globally, with limited access to effective treatment in many regions. The growing incidence of these conditions fuels the need for advanced treatment options beyond traditional grafts, making artificial corneas a critical alternative.
The global demographic shift toward an aging population intensifies demand for eye care services. Age-related corneal disorders, including Fuchs’ endothelial dystrophy and other degenerative changes, increase the need for corneal replacement procedures. Older patients often have comorbidities or ocular surface diseases that make donor grafts less viable and more prone to failure — circumstances where keratoprostheses provide a promising solution.
A major limiting factor for corneal transplants worldwide is the chronic shortage of suitable donor tissue. The Eye Bank Association of America estimates that the supply-demand gap remains significant even in developed countries, while in low- and middle-income countries, donor cornea availability is critically low. This persistent shortfall drives patients and surgeons to consider artificial corneas as an alternative, especially in cases of repeat graft failures.
Recent innovations in biomaterials, nanotechnology, and bioengineering have dramatically improved the safety, biocompatibility, and optical performance of artificial corneas. Advances include improved polymers that mimic natural corneal properties, integration techniques that promote tissue adherence, and designs that reduce the risk of extrusion or infection. Companies and research institutions are also exploring bioengineered and 3D-printed corneal substitutes, paving the way for scalable, cost-effective, and patient-specific implants.
LP Information, Inc. (LPI) ' newest research report, the “Artificial Cornea Industry Forecast” looks at past sales and reviews total world Artificial Cornea sales in 2024, providing a comprehensive analysis by region and market sector of projected Artificial Cornea sales for 2025 through 2031. With Artificial Cornea sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Cornea industry.
This Insight Report provides a comprehensive analysis of the global Artificial Cornea landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Cornea portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Cornea market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Cornea and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Cornea.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Cornea market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Boston Keratoprosthesis
OOKP
Other
Segmentation by Application:
Hospitals
Ophthalmology Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CorNeat Vision
EyeYon Medical
KeraMed
Aurolab
LinkoCare Life Sciences
MicroKPro
Biomedical Sciences
Yueqing Regenerative Medicin
Jiayue Meishi Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Cornea market?
What factors are driving Artificial Cornea market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Cornea market opportunities vary by end market size?
How does Artificial Cornea break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
100 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Artificial Cornea by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Artificial Cornea by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
